SCHEMBL1006191

SCHEMBL1006191

C[C@H](N)CN(C)Cc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CARM1 Q86X55 1/20 0.55
PRMT6 Q96LA8 1/20 0.55
PRMT8 Q9NR22 1/20 0.55
SLC6A2 P23975 3/20 0.52
TAAR1 Q96RJ0 2/20 0.52
MAOA P21397 2/20 0.52
SLC6A4 P31645 2/20 0.52
SLC6A3 Q01959 2/20 0.52
SIGMAR1 Q99720 2/20 0.52
AOC3 Q16853 1/20 0.52
CYP2A6 P11509 1/20 0.52
ADORA2A P29274 1/20 0.52
ADORA1 P30542 1/20 0.52
TSHR P16473 4/20 0.50
ALDH1A1 P00352 3/20 0.50
LMNA P02545 2/20 0.48
ADRA2B P18089 1/20 0.48
ADRA2C P18825 1/20 0.48
HTR2A P28223 1/20 0.48
ADRA1A P35348 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16209876 1.00 CARM1 (0.55) CARM1PRMT6PRMT8SLC6A2TAAR1
SCHEMBL3211466 1.00 CARM1 (0.55) CARM1PRMT6PRMT8SLC6A2TAAR1
Cadaverine Tartrate SCHEMBL28556768 0.87 MEN1 (0.50) CARM1PRMT6PRMT8TSHRALDH1A1
SCHEMBL8171045 0.85 CARM1 (0.52) CARM1PRMT6PRMT8SLC6A2TAAR1
SCHEMBL172668 0.83 TSHR (0.54) CARM1PRMT6PRMT8SLC6A2MAOA
SCHEMBL1839564 0.82 SLC6A2 (0.54) CARM1PRMT6PRMT8SLC6A2TAAR1
SCHEMBL1839568 0.82 SLC6A2 (0.54) CARM1PRMT6PRMT8SLC6A2TAAR1
SCHEMBL14085920 0.82 SLC6A2 (0.54) CARM1PRMT6PRMT8SLC6A2TAAR1
SCHEMBL23278222 0.81 CARM1 (0.61) CARM1PRMT6PRMT8SLC6A2TAAR1
SCHEMBL18711167 0.81 TAAR1 (0.55) CARM1PRMT6PRMT8SLC6A2TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7863271-B2 2-aminobenzoxazole carboxamides as 5HT3 modulators ALBANY MOLECULAR RESEARCH, INC. (US) 2011-01-04 US disclosed
US-20080255114-A1 2-AMINOBENZOXAZOLE CARBOXAMIDES AS 5HT3 MODULATORS AMR TECHNOLOGY, INC. (US) 2008-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255114-A1 2-AMINOBENZOXAZOLE CARBOXAMIDES AS 5HT3 MODULATORS HTR3E, HTR3C, HTR3A CARM1 4335/4885PRMT6 3609/4885PRMT8 3815/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.